This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ackermann, M R Articles by Thurston, J R Search for Related Content PubMed PubMed Citation Articles by Ackermann, M R Articles by Thurston, J R

 Previous Article  |  Next Article 

Infect Immun. 1991 October; 59(10): 3626-3629

Experimental model of atrophic rhinitis in gnotobiotic pigs.

Avian Diseases Research Unit, U.S. Department of Agriculture, Ames, Iowa 50010.

ABSTRACT

To study the pathogenesis of atrophic rhinitis, gnotobiotic pigs (n = 6) were inoculated intranasally with a sterile sonicate of a toxigenic strain of Bordetella bronchiseptica (0.16 mg of protein per ml) at 5 days of age, and they were then inoculated intranasally with 1 ml (5,250 CFU/ml) of a live, toxigenic strain of Pasteurella multocida at 7 days of age. Pigs were necropsied at 2, 5, 9, 14, 21, and 28 days postinoculation; those pigs necropsied after 5 days had developed turbinate atrophy. Other gnotobiotic pigs received the following inoculation protocols: (i) a sterile sonicate of a nontoxigenic strain of B. bronchiseptica (0.2 mg of protein per ml), followed by toxigenic P. multocida (n = 4); (ii) toxigenic P. multocida alone (n = 7); (iii) diluent (sterile tryptose broth) (n = 2); (iv) the sterile sonicate of toxigenic B. bronchiseptica alone (n = 2); or (v) the sterile sonicate of a nontoxigenic strain of B. bronchiseptica alone (n = 2). Turbinate atrophy did not occur in the latter groups except for one pig inoculated with only toxigenic P. multocida. These studies show that turbinate atrophy occurs in pigs given the toxigenic B. bronchiseptica sonicate and then given live, toxigenic P. multocida. This experimental regimen is a useful model for (i) studying the pathogenesis of atrophic rhinitis and (ii) testing vaccine strategies.

This article has been cited by other articles:

• Brockmeier, S. L., Register, K. B., Magyar, T., Lax, A. J., Pullinger, G. D., Kunkle, R. A. (2002). Role of the Dermonecrotic Toxin of Bordetella bronchiseptica in the Pathogenesis of Respiratory Disease in Swine. Infect. Immun. 70: 481-490 [Abstract] [Full Text]  
• Register, K. B., Ducey, T. F., Brockmeier, S. L., Dyer, D. W. (2001). Reduced Virulence of a Bordetella bronchiseptica Siderophore Mutant in Neonatal Swine. Infect. Immun. 69: 2137-2143 [Abstract] [Full Text]  
• Rambow, A. A., Fernandez, R. C., Weiss, A. A. (1998). Characterization of BrkA Expression in Bordetella bronchiseptica. Infect. Immun. 66: 3978-3980 [Abstract] [Full Text]  
• Horiguchi, Y, Senda, T, Sugimoto, N, Katahira, J, Matsuda, M (1995). Bordetella bronchiseptica dermonecrotizing toxin stimulates assembly of actin stress fibers and focal adhesions by modifying the small GTP-binding protein rho. J. Cell Sci. 108: 3243-3251 [Abstract]